Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sevelamer carbonate pilot study to lower FGF23 and assess pulse wave velocity in stage 3 chronic kidney disease
NL-OMON25966Not yet recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jan 2010
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Trial of sevelamer carbonate, sponsored by Vrije University Medical Center. Planned start Jan 2010; status: not yet recruiting.
02
Drugs
sevelamer carbonate
Beyond the preview
Go deeper on NL-OMON25966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON25966.